Should we apply?
7 questions about Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional). The first ones are deal-breakers: grant professionals check them before writing anything. We filled in what we know. Change anything that's wrong.